GAM
BSX icon

Grandview Asset Management’s Boston Scientific BSX Stock Holding History

Grandview Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$4K – 154
2021
Q1 		$4K Buy
+100
New +$3.79K ﹤0.01% 399

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Grandview Asset Management's BSX Position: Q2 2021 in Review

Grandview Asset Management sold out of Boston Scientific (BSX) in Q2 2021, closing a stake of 100 shares — an estimated $4K sold.

Grandview Asset Management first reported a position in BSX in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 867 funds tracked by Wall St. Rank hold BSX as of Q2 2021.

  • Grandview Asset Management reported no remaining Boston Scientific position as of Q2 2021 after selling out during the quarter.
  • Grandview Asset Management sold 100 Boston Scientific shares in Q2 2021, an estimated $4K.
  • Grandview Asset Management first reported a position in Boston Scientific in Q1 2021 and held it in 1 quarter.
  • Grandview Asset Management's Boston Scientific position peaked at $4K in Q1 2021.
  • 867 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2021.

Based on Grandview Asset Management's 13F filing for Q2 2021, filed 21 Jul 2021.